Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine - a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays

被引:51
作者
Noronha, Glenn
Barrett, Kathy
Boccia, Antonio
Brodhag, Tessa
Cao, Jianguo
Chow, Chun P.
Dneprovskaia, Elena
Doukas, John
Fine, Richard
Gong, Xianchang
Gritzen, Colleen
Gu, Hong
Hanna, Ehab
Hood, John D.
Hu, Steven
Kang, Xinshan
Key, Jann
Klebansky, Boris
Kousba, Ahmed
Li, Ge
Lohse, Dan
Mak, Chi Ching
McPherson, Andrew
Palanki, Moorthy S. S.
Pathak, Ved P.
Renick, Joel
Shi, Feng
Soll, Richard
Splittgerber, Ute
Stoughton, Silva
Tang, Suhan
Yee, Shiyin
Zeng, Binqi
Zhao, Ningning
Zhu, Hong
机构
[1] TargeGen Inc, San Diego, CA 92121 USA
[2] BioPredict Inc, Oradell, NJ 07649 USA
[3] Wuxi PharmaTech Ltd, Shanghai, Peoples R China
关键词
Src inhibitor; cancer; kinase inhibitor; benzotriazines;
D O I
10.1016/j.bmcl.2006.11.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe the identification of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-l-ylethoxy)phenyl]amine (3), a potent, orally active Src inhibitor with desirable PK properties, demonstrated activity in human tumor cell lines and in animal models of tumor growth. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:602 / 608
页数:7
相关论文
共 34 条
[1]   Closure between nitro- and amino groups under the formation of triazine [J].
Arndt, F .
BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, 1913, 46 :3522-3530
[2]   Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)-amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles [J].
Boschelli, DH ;
Wu, BQ ;
Sosa, ACB ;
Chen, JJ ;
Golas, JM ;
Boschelli, F .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) :4681-4684
[3]   Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles [J].
Boschelli, DH ;
Wu, B ;
Sosa, ACB ;
Durutlic, H ;
Chen, JJ ;
Wang, Y ;
Golas, JM ;
Lucas, J ;
Boschelli, F .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (11) :3891-3902
[4]   Identification of 7-phenylaxaminothieno[3,2-b]pyridine-6-carbonitriles as a new class of Src kinase inhibitors [J].
Boschelli, DH ;
Wu, BQ ;
Sosa, ACB ;
Durutlic, H ;
Ye, F ;
Raifeld, Y ;
Golas, JM ;
Boschelli, F .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) :6666-6668
[5]   Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src [J].
Calalb, MB ;
Zhang, XE ;
Polte, TR ;
Hanks, SK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (03) :662-668
[6]   Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation [J].
Carraro, F ;
Naldini, A ;
Pucci, A ;
Locatelli, GA ;
Maga, G ;
Schenone, S ;
Bruno, O ;
Ranise, A ;
Bondavalli, F ;
Brullo, C ;
Fossa, P ;
Menozzi, G ;
Mosti, L ;
Modugno, M ;
Tintori, C ;
Manetti, F ;
Botta, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (05) :1549-1561
[7]   Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds [J].
Dalgarno, D ;
Stehle, T ;
Narula, S ;
Schelling, P ;
van Schravendijk, MR ;
Adams, S ;
Andrade, L ;
Keats, J ;
Ram, M ;
Jin, L ;
Grossman, T ;
MacNeil, I ;
Metcalf, C ;
Shakespeare, W ;
Wang, Y ;
Keenan, T ;
Sundaramoorthi, R ;
Bohacek, R ;
Weigele, M ;
Sawyer, T .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (01) :46-57
[8]   Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability [J].
Eliceiri, BP ;
Paul, R ;
Schwartzberg, PL ;
Hood, JD ;
Leng, J ;
Cheresh, DA .
MOLECULAR CELL, 1999, 4 (06) :915-924
[9]   Studies of drug binding to plasma proteins using a variant of equilibrium dialysis [J].
Eriksson, MAL ;
Gabrielsson, J ;
Nilsson, LB .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 38 (03) :381-389
[10]  
HONOLD K, 2006, Patent No. 2006066913